Travel Vaccines Market Size, Share, and Growth 2024-2031
Travel Vaccines Market: Strategic Insights
Travel Vaccines Market
-
CAGR (2023 - 2031)8.7% -
Market Size 2023
US$ 4.2 Billion -
Market Size 2031
US$ 9.2 Billion
Market Dynamics
GROWTH DRIVERS
- Growing incidence of infectious diseases drives the market growth
- Rising International Travel Accelerates Demand for Travel Vaccines which is expected to Favor the Market Growth
FUTURE TRENDS
- Digitalization for travel vaccines are likely to remain key trends in the market.
OPPORTUNITIES
- Rising investment in Research & Development (R&D)for Travel Vaccine to Provide Lucrative Market Opportunities
Key Players
- GSK
- Merck Co Inc
- Sanofi
- Novartis
- Pfizer
- Dynavax Technologies
- Emergent Biosolutions Inc
- Abbott
- Bharat Biotech
- Valneva
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product
- Hepatitis A
- Hepatitis B
- Meningococcal Vaccines
- DPT
- Yellow Fever
- Typhoid
- Japanese Encephalitis
- Measles
- Mumps
- Rubella
- Rabies
- Polio
- Influenza
- Varicella & Shingles
- Cholera
Application
- Domestic Travel and Outbound Travel